{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:19:11Z","timestamp":1793395151659,"version":"4.5.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005713","name":"Technische Universit\u00e4t M\u00fcnchen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005713","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite the proven efficacy of antipsychotics in relapse prevention in schizophrenia and schizoaffective disorder, every third patient experiences a relapse within less than one year. Relapses can worsen psychosocial and treatment related outcomes and lead to substantial economic costs, primarily due to frequent and prolonged hospitalizations. The aim of this project is to evaluate a smartphone- and web-based digital solution for detecting early warning signs of schizophrenia and schizoaffective disorder to reduce relapses and subsequent hospitalizations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This randomized controlled trial compares the add-on use of a smartphone-based app for monitoring relapse warning signs in patients with schizophrenia and schizoaffective disorders (ICD-10 F20\/F25) used within the routine psychiatric outpatient treatment against treatment as usual (TAU) without any further study-related intervention. Patients in the intervention group use the app for one year, fill in the weekly ten-item Early Warning Signs Questionnaire (EWSQ-10P) and obtain in-app feedback. Clinicians can access the symptom trajectory via a browser-accessible dashboard. If a threshold is exceeded in the inbuilt automatic algorithm, an alert is sent to both, the clinician and patient, enabling timely contact and, as part of a shared decision-making process, an optional adjustment of treatment decision. A total of 110 outpatients are recruited across eight study sites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Continuous monitoring of early warning signs is expected to lead to behavioral changes and to decrease the necessity and duration of psychiatric hospital stays, thereby lowering healthcare costs. Additionally, the intervention could reduce symptom severity, alleviate medication adherence, shared decision-making, patient activation or quality of life. Qualitative data is collected to better understand patient needs and preferences regarding app usage and relapses. Insights gained from this study can be integrated into routine psychiatric care, improving the long-term treatment of patients with schizophrenia or schizoaffective disorder.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>German Clinical Trials Register (ID: DRKS00034991; registration date: 30.08.2024).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00406-025-02089-7","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T04:39:25Z","timestamp":1755578365000},"page":"637-650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The ILIA study: protocol for a randomized-controlled multicenter clinical trial on smartphone- and web-based relapse monitoring for patients with schizophrenia or schizoaffective disorder"],"prefix":"10.1007","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0041-7722","authenticated-orcid":false,"given":"Selina","family":"Hiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Emde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Jais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So\u0148a Nevick\u00e1","family":"Sikorov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Bakstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"\u0160paniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate\u0159ina","family":"Urbanov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zierhut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"F\u00fcrstenau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"B\u00fchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Maurus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Pogarell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Falkai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Strube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Skuban-Eiseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Priller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Brieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Heres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkomiet","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerem","family":"B\u00f6ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"2089_CR1","doi-asserted-by":"crossref","unstructured":"Lauriello J (2020) Prevalence and impact of relapse in patients with schizophrenia. J Clin Psychiatry 10.4088\/JCP.MS19053BR1C.","DOI":"10.4088\/JCP.MS19053BR1C"},{"issue":"3","key":"2089_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","volume":"56","author":"D Robinson","year":"1999","unstructured":"Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, Koreen A, Sheitman B, Chakos M, Mayerhoff D, Lieberman JA (1999) Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 56(3):241\u2013247","journal-title":"Arch Gen Psychiatry"},{"key":"2089_CR3","doi-asserted-by":"crossref","unstructured":"Brieger P, Marneros A, J\u00e4ger M (2017) Schizoaffektive St\u00f6rungen, akute vor\u00fcbergehende psychotische St\u00f6rungen und wahnhafte St\u00f6rungen. In: M\u00f6ller H-J, Laux G, Kapfhammer H-P, editors. Psychiatrie, Psychosomatik, Psychotherapie: Band 1: Allgemeine Psychiatrie 1, Band 2: Allgemeine Psychiatrie 2, Band 3: Spezielle Psychiatrie 1, Band 4: Spezielle Psychiatrie 2. Berlin, Heidelberg: Springer Berlin Heidelberg; ISBN:978-3-662-49295-6. pp. 1675\u20131700","DOI":"10.1007\/978-3-662-49295-6_65"},{"key":"2089_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.schres.2019.08.035","volume":"225","author":"J Moncrieff","year":"2020","unstructured":"Moncrieff J, Crellin NE, Long MA, Cooper RE, Stockmann T (2020) Definitions of relapse in trials comparing antipsychotic maintenance with discontinuation or reduction for schizophrenia spectrum disorders: A systematic review. Schizophr Res 225:47\u201354","journal-title":"Schizophr Res"},{"issue":"1","key":"2089_CR5","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1744-859X-12-32","volume":"12","author":"JM Olivares","year":"2013","unstructured":"Olivares JM, Sermon J, Hemels M, Schreiner A (2013) Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review. Ann Gen Psychiatry 12(1):32","journal-title":"Ann Gen Psychiatry"},{"issue":"1","key":"2089_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S2215-0366(23)00364-4","volume":"11","author":"S Siafis","year":"2024","unstructured":"Siafis S, Brandt L, McCutcheon RA, Gutwinski S, Schneider-Thoma J, Bighelli I, Kane JM, Arango C, Kahn RS, Fleischhacker WW, McGorry P, Carpenter WT, Falkai P, Hasan A, Marder SR, Schooler N, Engel RR, Honer WG, Buchanan RW, Davidson M, Weiser M, Priller J, Davis JM, Howes OD, Correll CU, Leucht S (2024) Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis. Lancet Psychiatry 11(1):36\u201346","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"2089_CR7","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1007\/s00115-010-3202-6","volume":"82","author":"J Zimmermann","year":"2011","unstructured":"Zimmermann J, Wolter A, Krischke NR, Preu\u00df UW, Wobrock T, Falkai P (2011) Response und remission Bei an schizophrenie erkrankten patienten. Nervenarzt 82(11):1440\u20131448. https:\/\/doi.org\/10.1007\/s00115-010-3202-6","journal-title":"Nervenarzt"},{"key":"2089_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eurpsy.2019.06.001","volume":"61","author":"A Murru","year":"2019","unstructured":"Murru A, Verdolini N, Anmella G, Pacchiarotti I, Samalin L, Aedo A, Undurraga J, Goikolea JM, Amann BL, Carvalho AF, Vieta E (2019) A 12-month prospective study on the time to hospitalization and clinical management of a cohort of bipolar type I and schizoaffective bipolar patients. Eur Psychiatry 61:1\u20138","journal-title":"Eur Psychiatry"},{"issue":"9831","key":"2089_CR9","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","volume":"379","author":"S Leucht","year":"2012","unstructured":"Leucht S, Tardy M, Komossa K, Heres S, Kissling W, Salanti G, Davis JM (2012) Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet 379(9831):2063\u20132071","journal-title":"Lancet"},{"issue":"8","key":"2089_CR10","first-page":"CD008016","volume":"8","author":"A Ceraso","year":"2020","unstructured":"Ceraso A, Lin JJ, Schneider-Thoma J, Siafis S, Tardy M, Komossa K, Heres S, Kissling W, Davis JM, Leucht S (2020) Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev 8(8):CD008016","journal-title":"Cochrane Database Syst Rev"},{"key":"2089_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1192\/bjp.184.4.346","volume":"184","author":"S Almond","year":"2004","unstructured":"Almond S, Knapp M, Francois C, Toumi M, Brugha T (2004) Relapse in schizophrenia: costs, clinical outcomes and quality of life. Br J Psychiatry 184:346\u2013351","journal-title":"Br J Psychiatry"},{"issue":"6","key":"2089_CR12","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41386-018-0278-3","volume":"44","author":"H Takeuchi","year":"2019","unstructured":"Takeuchi H, Siu C, Remington G, Fervaha G, Zipursky RB, Foussias G, Agid O (2019) Does relapse contribute to treatment resistance? Antipsychotic response in first- vs. second-episode schizophrenia. Neuropsychopharmacology 44(6):1036\u20131042","journal-title":"Neuropsychopharmacology"},{"key":"2089_CR13","doi-asserted-by":"publisher","first-page":"695672","DOI":"10.3389\/fpsyt.2021.695672","volume":"12","author":"D Lin","year":"2021","unstructured":"Lin D, Joshi K, Keenan A, Shepherd J, Bailey H, Berry M, Wright J, Meakin S, Benson C, Kim E (2021) Associations between relapses and psychosocial outcomes in patients with schizophrenia in Real-World settings in the united States. Front Psychiatry 12:695672","journal-title":"Front Psychiatry"},{"issue":"7","key":"2089_CR14","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s00127-022-02220-2","volume":"57","author":"Z Zukowska","year":"2022","unstructured":"Zukowska Z, Allan S, Eisner E, Ling L, Gumley A (2022) Fear of relapse in schizophrenia: a mixed-methods systematic review. Soc Psychiatry Psychiatr Epidemiol 57(7):1305\u20131318","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"1","key":"2089_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/bjc.12060","volume":"54","author":"A Gumley","year":"2015","unstructured":"Gumley A, MacBeth A, Reilly JD, O\u2019Grady M, White RG, McLeod H, Schwannauer M, Power KG (2015) Fear of recurrence: results of a randomized trial of relapse detection in schizophrenia. Br J Clin Psychol 54(1):49\u201362","journal-title":"Br J Clin Psychol"},{"issue":"3","key":"2089_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40258-014-0095-8","volume":"12","author":"S Karve","year":"2014","unstructured":"Karve S, Markowitz M, Fu D-J, Lindenmayer J-P, Wang C-C, Candrilli SD, Alphs L (2014) Assessing medication adherence and healthcare utilization and cost patterns among hospital-discharged patients with schizoaffective disorder. Appl Health Econ Health Policy 12(3):335\u2013346","journal-title":"Appl Health Econ Health Policy"},{"issue":"9","key":"2089_CR17","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s40273-017-0515-3","volume":"35","author":"M Pennington","year":"2017","unstructured":"Pennington M, McCrone P (2017) The cost of relapse in schizophrenia. PharmacoEconomics 35(9):921\u2013936","journal-title":"PharmacoEconomics"},{"key":"2089_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-244X-10-2","volume":"10","author":"H Ascher-Svanum","year":"2010","unstructured":"Ascher-Svanum H, Zhu B, Faries DE, Salkever D, Slade EP, Peng X, Conley RR (2010) The cost of relapse and the predictors of relapse in the treatment of schizophrenia. BMC Psychiatry 10:2","journal-title":"BMC Psychiatry"},{"issue":"3","key":"2089_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/schbul\/21.3.419","volume":"21","author":"PJ Weiden","year":"1995","unstructured":"Weiden PJ, Olfson M (1995) Cost of relapse in schizophrenia. Schizophr Bull 21(3):419\u2013429","journal-title":"Schizophr Bull"},{"key":"2089_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.eurpsy.2017.10.008","volume":"48","author":"G Kov\u00e1cs","year":"2018","unstructured":"Kov\u00e1cs G, Alm\u00e1si T, Millier A, Toumi M, Horv\u00e1th M, K\u00f3czi\u00e1n K, G\u00f6tze \u00c1, Kal\u00f3 Z, Zempl\u00e9nyi AT (2018) Direct healthcare cost of schizophrenia - European overview. Eur Psychiatry 48:79\u201392","journal-title":"Eur Psychiatry"},{"key":"2089_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1192\/bjp.172.4.327","volume":"172","author":"P J\u00f8rgensen","year":"1998","unstructured":"J\u00f8rgensen P (1998) Early signs of psychotic relapse in schizophrenia. Br J Psychiatry 172:327\u2013330","journal-title":"Br J Psychiatry"},{"issue":"2","key":"2089_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1440-0979.2004.00314.x","volume":"13","author":"B van Meijel","year":"2004","unstructured":"van Meijel B, van der Gaag M, Kahn RS, Grypdonck MHF (2004) Recognition of early warning signs in patients with schizophrenia: a review of the literature. Int J Ment Health Nurs 13(2):107\u2013116","journal-title":"Int J Ment Health Nurs"},{"key":"2089_CR23","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.cpr.2023.102357","volume":"107","author":"JF Gleeson","year":"2024","unstructured":"Gleeson JF, McGuckian TB, Fernandez DK, Fraser MI, Pepe A, Taskis R, Alvarez-Jimenez M, Farhall JF, Gumley A (2024) Systematic review of early warning signs of relapse and behavioural antecedents of symptom worsening in people living with schizophrenia spectrum disorders. Clin Psychol Rev 107:102357","journal-title":"Clin Psychol Rev"},{"key":"2089_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neulet.2016.04.044","volume":"669","author":"F \u0160paniel","year":"2018","unstructured":"\u0160paniel F, Bakstein E, Anyz J, Hlinka J, Sieger T, Hrdlicka J, G\u00f6rnerov\u00e1 N, H\u00f6schl C (2018) Relapse in schizophrenia: definitively not a bolt from the blue. Neurosci Lett 669:68\u201374","journal-title":"Neurosci Lett"},{"issue":"2","key":"2089_CR25","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1139\/jpn.0311","volume":"28","author":"J Addington","year":"2003","unstructured":"Addington J (2003) The prodromal stage of psychotic illness: observation, detection or intervention? J Psychiatry Neurosci 28(2):93\u201397","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"2089_CR26","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0022-3956(93)90059-B","volume":"27","author":"A Pietzcker","year":"1993","unstructured":"Pietzcker A, Wolfgang G, Wolfgang K, Michael L, Peter M, Franz M-S, Joachim T (1993) Intermittent versus maintenance neuroleptic long-term treatment in Schizophrenia\u20142-year results of a German multicenter study. J Psychiatr Res 27(4):321\u2013339. https:\/\/doi.org\/10.1016\/0022-3956(93)90059-B","journal-title":"J Psychiatr Res"},{"issue":"1\u20133","key":"2089_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.schres.2007.09.005","volume":"98","author":"F \u0160paniel","year":"2008","unstructured":"\u0160paniel F, Vohl\u00eddka P, Hrdlicka J, Kozen\u00fd J, Nov\u00e1k T, Motlov\u00e1 L, Cerm\u00e1k J, Bednar\u00edk J, Nov\u00e1k D, H\u00f6schl C (2008) ITAREPS: information technology aided relapse prevention programme in schizophrenia. Schizophr Res 98(1\u20133):312\u2013317","journal-title":"Schizophr Res"},{"issue":"1","key":"2089_CR28","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.schres.2013.08.007","volume":"150","author":"H Komatsu","year":"2013","unstructured":"Komatsu H, Sekine Y, Okamura N, Kanahara N, Okita K, Matsubara S, Hirata T, Komiyama T, Watanabe H, Minabe Y, Iyo M (2013) Effectiveness of information technology aided relapse prevention programme in schizophrenia excluding the effect of user adherence: a randomized controlled trial. Schizophr Res 150(1):240\u2013244","journal-title":"Schizophr Res"},{"issue":"7","key":"2089_CR29","doi-asserted-by":"publisher","first-page":"992","DOI":"10.4088\/JCP.v68n0703","volume":"68","author":"J Hamann","year":"2007","unstructured":"Hamann J, Cohen R, Leucht S, Busch R, Kissling W (2007) Shared decision making and long-term outcome in schizophrenia treatment. J Clin Psychiatry 68(7):992\u2013997","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"2089_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1192\/bjp.bp.114.158931","volume":"209","author":"D Stovell","year":"2016","unstructured":"Stovell D, Morrison AP, Panayiotou M, Hutton P (2016) Shared treatment decision-making and empowerment-related outcomes in psychosis: systematic review and meta-analysis. Br J Psychiatry 209(1):23\u201328","journal-title":"Br J Psychiatry"},{"issue":"8","key":"2089_CR31","doi-asserted-by":"publisher","first-page":"e26348","DOI":"10.2196\/26348","volume":"8","author":"J An\u00fd\u017e","year":"2021","unstructured":"An\u00fd\u017e J, Bak\u0161tein E, Dally A, Koleni\u010d M, Hlinka J, Hartmannov\u00e1 T, Urbanov\u00e1 K, Correll CU, Nov\u00e1k D, \u0160paniel F (2021) Validity of the Aktibipo Self-rating questionnaire for the digital Self-assessment of mood and relapse detection in patients with bipolar disorder: instrument validation study. JMIR Ment Health 8(8):e26348","journal-title":"JMIR Ment Health"},{"issue":"2","key":"2089_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf 42(2):377\u2013381","journal-title":"J Biomed Inf"},{"key":"2089_CR33","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN (2019) The REDCap consortium: Building an international community of software platform partners. J Biomed Inf 95:103208","journal-title":"J Biomed Inf"},{"key":"2089_CR34","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jpsychires.2018.11.025","volume":"109","author":"L Hendrikoff","year":"2019","unstructured":"Hendrikoff L, Kambeitz-Ilankovic L, Pryss R, Senner F, Falkai P, Pogarell O, Hasan A, Peters H (2019) Prospective acceptance of distinct mobile mental health features in psychiatric patients and mental health professionals. J Psychiatr Res 109:126\u2013132","journal-title":"J Psychiatr Res"},{"key":"2089_CR35","doi-asserted-by":"publisher","unstructured":"Soellner R, Huber S, Reder M (2014) The concept of eHealth literacy and its measurement: German translation of the eHEALS. J Media Psychology: Theor Methods Appl 26(1). https:\/\/doi.org\/10.1027\/1864-1105\/a000104","DOI":"10.1027\/1864-1105\/a000104"},{"issue":"1","key":"2089_CR36","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.pec.2009.09.034","volume":"80","author":"L Kriston","year":"2010","unstructured":"Kriston L, Scholl I, H\u00f6lzel L, Simon D, Loh A, H\u00e4rter M (2010) The 9-item shared decision making questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample. Patient Educ Couns 80(1):94\u201399","journal-title":"Patient Educ Couns"},{"key":"2089_CR37","unstructured":"Juergen S, N\u00fcbling R (2002) ZUF-8. Fragebogen zur Messung der Patientenzufriedenheit. In: Diagnostische Verfahren in der Psychotherapie; ISBN:978-3-8017-1289-1. pp. 392\u2013396"},{"key":"2089_CR38","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1186\/1471-2458-13-1027","volume":"13","author":"JM Zill","year":"2013","unstructured":"Zill JM, Dwinger S, Kriston L, Rohenkohl A, H\u00e4rter M, Dirmaier J (2013) Psychometric evaluation of the German version of the patient activation measure (PAM13). BMC Public Health 13:1027","journal-title":"BMC Public Health"},{"issue":"3","key":"2089_CR39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.sapharm.2023.11.005","volume":"20","author":"I Arnet","year":"2024","unstructured":"Arnet I, Sahm LJ, Greg\u00f3rio J, Tuula A, Kr\u00fcger M, Wurmbach VS, Hoti K, Schulz M, Eickhoff C (2024) Development and validation of the 15-STARS - A novel self-report pharmacy-based questionnaire to screen for medication non-adherence. Res Social Adm Pharm 20(3):308\u2013320","journal-title":"Res Social Adm Pharm"},{"issue":"6","key":"2089_CR40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/acps.12526","volume":"133","author":"SD \u00d8stergaard","year":"2016","unstructured":"\u00d8stergaard SD, Lemming OM, Mors O, Correll CU, Bech P (2016) PANSS-6: a brief rating scale for the measurement of severity in schizophrenia. Acta Psychiatr Scand 133(6):436\u2013444","journal-title":"Acta Psychiatr Scand"},{"key":"2089_CR41","doi-asserted-by":"crossref","unstructured":"Haro JM, Kamath SA, Ochoa S, Novick D, Rele K, Fargas A, Rodr\u00edguez MJ, Rele R, Orta J, Kharbeng A, Araya S, Gervin M, Alonso J, Mavreas V, Lavrentzou E, Liontos N, Gregor K, Jones PB (2003) The clinical global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl 107(416):16\u201323","DOI":"10.1034\/j.1600-0447.107.s416.5.x"},{"issue":"4","key":"2089_CR42","first-page":"323","volume":"101","author":"PL Morosini","year":"2000","unstructured":"Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R (2000) Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 101(4):323\u2013329","journal-title":"Acta Psychiatr Scand"},{"issue":"2","key":"2089_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1026\/0012-1924.53.2.83","volume":"53","author":"E Br\u00e4hler","year":"2007","unstructured":"Br\u00e4hler E, M\u00fchlan H, Albani C, Schmidt S (2007) Teststatistische Pr\u00fcfung und normierung der Deutschen versionen des EUROHIS-QOL Lebensqualit\u00e4t-index und des WHO-5 Wohlbefindens-index. [Testing and standardization of the German version of the EUROHIS-QOL and WHO-5 quality-of life-indices]. Diagnostica 53(2):83\u201396. https:\/\/doi.org\/10.1026\/0012-1924.53.2.83","journal-title":"Diagnostica"},{"issue":"11","key":"2089_CR44","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2471\/BLT.09.067231","volume":"88","author":"TB Ust\u00fcn","year":"2010","unstructured":"Ust\u00fcn TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, Saxena S, von Korff M (2010) Pull C. Developing the world health organization disability assessment schedule 2.0. Bull World Health Organ 88(11):815\u2013823","journal-title":"Bull World Health Organ"},{"key":"2089_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","volume":"334","author":"O Lingjaerde","year":"1987","unstructured":"Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K (1987) The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 334:1\u2013100","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"1","key":"2089_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mhp.2016.01.004","volume":"4","author":"E Vo\u00df","year":"2016","unstructured":"Vo\u00df E, Salize HJ (2016) Health care utilization and cost-effectiveness analyses in prevention studies in the mental health care field. Mental Health Prev 4(1):19\u201323. https:\/\/doi.org\/10.1016\/j.mhp.2016.01.004","journal-title":"Mental Health Prev"},{"key":"2089_CR47","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3389\/fpsyt.2020.00600","volume":"11","author":"K B\u00f6ge","year":"2020","unstructured":"B\u00f6ge K, Karadza A, Fuchs LM, Ehlen F, Ta TMT, Thomas N, Bajbouj M, Hahn E (2020) Mindfulness-Based interventions for In-Patients with schizophrenia spectrum Disorders-A qualitative approach. Front Psychiatry 11:600","journal-title":"Front Psychiatry"},{"key":"2089_CR48","doi-asserted-by":"publisher","first-page":"715670","DOI":"10.3389\/fpsyt.2021.715670","volume":"12","author":"T Schulze","year":"2021","unstructured":"Schulze T, Hahn E, Hahne I, Bergmann N, Fuchs LM, M\u00e4hler F, Zierhut MM, Ta TMT, Pijnenborg GHM, B\u00f6ge K (2021) Yoga-Based group intervention for In-patients with schizophrenia spectrum Disorders-A qualitative approach. Front Psychiatry 12:715670","journal-title":"Front Psychiatry"},{"key":"2089_CR49","doi-asserted-by":"publisher","first-page":"1086468","DOI":"10.3389\/fpsyt.2023.1086468","volume":"14","author":"L T\u00f6belmann","year":"2023","unstructured":"T\u00f6belmann L, Hahne I, Schulze T, Bergmann N, Fuchs L, Zierhut M, Hahn E, B\u00f6ge K (2023) Mechanisms of action and processes of yoga-based group intervention for inpatients with schizophrenia spectrum disorders-A longitudinal qualitative study. Front Psychiatry 14:1086468","journal-title":"Front Psychiatry"},{"key":"2089_CR50","doi-asserted-by":"publisher","first-page":"114523","DOI":"10.1016\/j.socscimed.2021.114523","volume":"292","author":"M Hennink","year":"2022","unstructured":"Hennink M, Kaiser BN (2022) Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med 292:114523","journal-title":"Soc Sci Med"},{"issue":"4","key":"2089_CR51","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/ije\/dyz032","volume":"48","author":"RA Hughes","year":"2019","unstructured":"Hughes RA, Heron J, Sterne JAC, Tilling K (2019) Accounting for missing data in statistical analyses: multiple imputation is not always the answer. Int J Epidemiol 48(4):1294\u20131304","journal-title":"Int J Epidemiol"},{"issue":"9","key":"2089_CR52","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1177\/0962280216683570","volume":"27","author":"TR Sullivan","year":"2018","unstructured":"Sullivan TR, White IR, Salter AB, Ryan P, Lee KJ (2018) Should multiple imputation be the method of choice for handling missing data in randomized trials? Stat Methods Med Res 27(9):2610\u20132626","journal-title":"Stat Methods Med Res"},{"key":"2089_CR53","doi-asserted-by":"publisher","first-page":"b3496","DOI":"10.1136\/bmj.b3496","volume":"339","author":"S Lewin","year":"2009","unstructured":"Lewin S, Glenton C, Oxman AD (2009) Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study. BMJ 339:b3496","journal-title":"BMJ"},{"key":"2089_CR54","doi-asserted-by":"publisher","first-page":"h1258","DOI":"10.1136\/bmj.h1258","volume":"350","author":"GF Moore","year":"2015","unstructured":"Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, Moore L, O\u2019Cathain A, Tinati T, Wight D, Baird J (2015) Process evaluation of complex interventions: medical research Council guidance. BMJ 350:h1258","journal-title":"BMJ"},{"key":"2089_CR55","doi-asserted-by":"crossref","unstructured":"Hepburn A, Bolden GB The Conversation Analytic Approach to Transcription. The handbook of conversation analysis 2012:57\u201376","DOI":"10.1002\/9781118325001.ch4"},{"key":"2089_CR56","unstructured":"Kuckartz U, R\u00e4diker S (2022) Qualitative inhaltsanalyse. Methoden, praxis, computerunterst\u00fctzung, 5th edn. Beltz Juventa"},{"key":"2089_CR57","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.schres.2024.04.013","volume":"267","author":"J Torous","year":"2024","unstructured":"Torous J, Smith KA, Hardy A, Vinnikova A, Blease C, Milligan L, Hidalgo-Mazzei D, Lambe S, Marzano L, Uhlhaas PJ, Ostinelli EG, Anmella G, Zangani C, Aronica R, Dwyer B, Cipriani A (2024) Digital health interventions for schizophrenia: setting standards for mental health. Schizophr Res 267:392\u2013395","journal-title":"Schizophr Res"},{"issue":"5","key":"2089_CR58","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1093\/schbul\/sby081","volume":"44","author":"MH Lim","year":"2018","unstructured":"Lim MH, Penn DL (2018) Using digital technology in the treatment of schizophrenia. Schizophr Bull 44(5):937\u2013938","journal-title":"Schizophr Bull"},{"issue":"4","key":"2089_CR59","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.2196\/mhealth.4930","volume":"3","author":"J Firth","year":"2015","unstructured":"Firth J, Torous J (2015) Smartphone apps for schizophrenia: A systematic review. JMIR Mhealth Uhealth 3(4):e102","journal-title":"JMIR Mhealth Uhealth"},{"issue":"6","key":"2089_CR60","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S2215-0366(22)00145-6","volume":"9","author":"TA Furukawa","year":"2022","unstructured":"Furukawa TA, Bighelli I (2022) Digital aids for relapse prevention in schizophrenia. Lancet Psychiatry 9(6):424\u2013425","journal-title":"Lancet Psychiatry"},{"key":"2089_CR61","doi-asserted-by":"crossref","unstructured":"Arnautovska U, Trott M, Vitangcol KJ, Milton A, Brown E, Warren N, Leucht S, Firth J, Siskind D, Morales-Pillado C, Fern\u00e1ndez-Castilla B, S\u00e1nchez-Guti\u00e9rrez T, Gonz\u00e1lez-Fraile E, Barbeito S, Calvo A (2023) Efficacy of technology-based interventions in psychosis: a systematic review and network meta-analysis. Psychol Med ;53(13):6304\u20136315","DOI":"10.1017\/S0033291722003610"},{"key":"2089_CR62","doi-asserted-by":"crossref","unstructured":"Morales-Pillado C, Fern\u00e1ndez-Castilla B, S\u00e1nchez-Guti\u00e9rrez T, Gonz\u00e1lez-Fraile E, Barbeito S, Calvo A. Efficacy of technology-based interventions in psychosis: a systematic review and network meta-analysis. Psychol Med 2023;53(13):6304\u20136315","DOI":"10.1017\/S0033291722003610"},{"key":"2089_CR63","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41746-020-0221-y","volume":"3","author":"RT Sutton","year":"2020","unstructured":"Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI (2020) An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med 3:17","journal-title":"NPJ Digit Med"},{"issue":"11","key":"2089_CR64","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1176\/ps.62.11.pss6211_1296","volume":"62","author":"DM Steinwachs","year":"2011","unstructured":"Steinwachs DM, Roter DL, Skinner EA, Lehman AF, Fahey M, Cullen B, Everett AS, Gallucci G (2011) A web-based program to empower patients who have schizophrenia to discuss quality of care with mental health providers. Psychiatric Serv 62(11):1296\u20131302","journal-title":"Psychiatric Serv"},{"issue":"1","key":"2089_CR65","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1186\/s12888-023-05023-0","volume":"23","author":"H Yu","year":"2023","unstructured":"Yu H, Sun Y-J, Qin M-N, Ren J-X, Yu K, Song J, Zhou Y-Q, Liu L (2023) Perception of risk of relapse among patients with first episode and recurrent schizophrenia: a descriptive phenomenological study. BMC Psychiatry 23(1):582","journal-title":"BMC Psychiatry"},{"issue":"2","key":"2089_CR66","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/NMD.0000000000001421","volume":"210","author":"ML Ybarra","year":"2022","unstructured":"Ybarra ML, Rodriguez KM, Fehmie DA, Mojtabai R, Cullen B (2022) Acceptability of texting 4 relapse prevention, text Messaging-Based relapse prevention program for people with schizophrenia and schizoaffective disorder. J Nerv Ment Dis 210(2):123\u2013128","journal-title":"J Nerv Ment Dis"},{"issue":"45 Suppl 1","key":"2089_CR67","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1093\/schbul\/sby103","volume":"45","author":"N Thomas","year":"2019","unstructured":"Thomas N, Bless JJ, Alderson-Day B, Bell IH, Cella M, Craig T, Delespaul P, Hugdahl K, Laloyaux J, Lar\u00f8i F, Lincoln TM, Schlier B, Urwyler P, van den Berg D, Jardri R (2019) Potential applications of digital technology in assessment, treatment, and Self-help for hallucinations. Schizophr Bull 45(45 Suppl 1):S32\u2013S42","journal-title":"Schizophr Bull"},{"issue":"10","key":"2089_CR68","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/NMD.0000000000001037","volume":"207","author":"ML Ybarra","year":"2019","unstructured":"Ybarra ML, Rodriguez K, Madison H, Mojtabai R, Cullen BA (2019) Developing texting for relapse prevention: A scalable mHealth program for people with schizophrenia and schizoaffective disorder. J Nerv Ment Dis 207(10):854\u2013862","journal-title":"J Nerv Ment Dis"},{"issue":"10","key":"2089_CR69","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/jpm.12251","volume":"22","author":"F \u0160paniel","year":"2015","unstructured":"\u0160paniel F, Nov\u00e1k T, Bankovska Motlova L, Capkova J, Slovakova A, Trancik P, Matejka M, H\u00f6schl C (2015) Psychiatrist\u2019s adherence: a new factor in relapse prevention of schizophrenia. A randomized controlled study on relapse control through telemedicine system. J Psychiatr Ment Health Nurs 22(10):811\u2013820","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"4","key":"2089_CR70","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/01.pra.0000416017.45591.c1","volume":"18","author":"F \u0160paniel","year":"2012","unstructured":"\u0160paniel F, Hrdli\u010dka J, Nov\u00e1k T, Ko\u017een\u00fd J, H\u00f6schl C, Mohr P, Motlov\u00e1 LB (2012) Effectiveness of the information technology-aided program of relapse prevention in schizophrenia (ITAREPS): a randomized, controlled, double-blind study. J Psychiatr Pract 18(4):269\u2013280","journal-title":"J Psychiatr Pract"},{"issue":"1","key":"2089_CR71","doi-asserted-by":"publisher","first-page":"e15058","DOI":"10.2196\/15058","volume":"9","author":"A Gumley","year":"2020","unstructured":"Gumley A, Bradstreet S, Ainsworth J, Allan S, Alvarez-Jimenez M, Beattie L, Bell I, Birchwood M, Briggs A, Bucci S, Castagnini E, Clark A, Cotton SM, Engel L, French P, Lederman R, Lewis S, Machin M, MacLennan G, Matrunola C, McLeod H, McMeekin N, Mihalopoulos C, Morton E, Norrie J, Reilly F, Schwannauer M, Singh SP, Smith L, Sundram S, Thomson D, Thompson A, Whitehill H, Wilson-Kay A, Williams C, Yung A, Farhall J, Gleeson J (2020) Early signs monitoring to prevent relapse in psychosis and promote Well-Being, engagement, and recovery: protocol for a feasibility cluster randomized controlled trial Harnessing mobile phone technology blended with peer support. JMIR Res Protoc 9(1):e15058","journal-title":"JMIR Res Protoc"},{"issue":"6","key":"2089_CR72","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S2215-0366(22)00103-1","volume":"9","author":"A Gumley","year":"2022","unstructured":"Gumley A, Bradstreet S, Ainsworth J, Allan S, Alvarez-Jimenez M, Aucott L, Birchwood M, Briggs A, Bucci S, Cotton SM, Engel L, French P, Lederman R, Lewis S, Machin M, MacLennan G, McLeod H, McMeekin N, Mihalopoulos C, Morton E, Norrie J, Schwannauer M, Singh SP, Sundram S, Thompson A, Williams C, Yung AR, Farhall J, Gleeson J (2022) The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia. Lancet Psychiatry 9(6):477\u2013486","journal-title":"Lancet Psychiatry"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-02089-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-025-02089-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-02089-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:02:05Z","timestamp":1772478125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-025-02089-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2089"],"URL":"https:\/\/doi.org\/10.1007\/s00406-025-02089-7","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to the indication of co\u2013first authorship were missing, Now it has been updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In the last three years SL has received honoraria for advising\/consulting and\/or for lectures and\/or for educational material from Angelini, Apsen, Boehringer Ingelheim, Eisai, Ekademia, GedeonRichter, Janssen, Karuna, Kynexis, Lundbeck, Medichem, Medscape, Mitsubishi, Neurotorium, Otsuka, NovoNordisk, Recordati, Rovi, Teva. AH is editor of the German (DGPPN) schizophrenia treatment guidelines, first author of the WFSBP schizophrenia treatment guidelines; on advisory boards of and speaker fees from AbbVie, Advanz (speaker fees only), Janssen-Cilag, Lundbeck, Recordati, Rovi, Teva, and Otsuka. KB has received honoraria for advising\/consulting and\/or for lectures and\/or for educational material from B\u00f6hringer Ingelheim and Angelini. KB is a co-founder of the digital healthcare start-ups KISO Health and MentalHub. MZ has received honoraria for lectures or advisory activities from Boehringer-Ingelheim. PF has received research support or honoraria for lectures or advisory activities from Boehringer-Ingelheim, Janssen, Lundbeck, Otsuka, Recordati and Richter. IM has received speaker fees from Boehringer Ingelheim. SS, EB and KU are employees and\/or shareholders of Mindpax.me.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the review board of the Ethics Committee of the Technical University of Munich (approval number 2024-242-S-KK). The responsible ethics committees for the participating clinics have followed this vote accordingly. This scientific study aims to examine whether smartphone-based symptom monitoring triggers positive effects on patient-relevant outcomes. The smartphone app is not intended to be further developed as a medical product or to pursue a commercial interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Patients meeting inclusion criteria are asked to provide informed consent (template of the informed consent form available upon request) for study participation, and their capability to provide informed consent is ensured by trained study staff. Consent can be withdrawn at any time, without giving reasons and without disadvantages for further medical care. Should the study be terminated by the clinician or patient, the data stored up to this point will continue to be used unless the patient or caregiver explicitly withdraws the release of their patient data. In the event of withdrawal of consent, the stored data will be destroyed at the patient\u2019s request. Data is saved and exchanged exclusively in pseudonymized forms. The pseudonyms represent patient\u00b4s affiliations with the respective outpatient clinic and do not include any identifying information such as date of birth or initials. The names of the patients and all other confidential information are subject to medical confidentiality and the provisions of the Federal Data Protection Act. The consent form and personal data remain in the recruiting center.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}